Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Side Effects Comparison# Retatrutide Side Effects# Phase 2 data (n=338 obesity trial): Nausea : ~25% at higher doses (8-12 mg) Diarrhea : ~20% Vomiting : ~15% Constipation : Common Decreased appetite : Common (pharmacological effect) Heart rate : Small increase (2-4 bpm), potentially related to glucagon component Injection site reactions : Mild, transient Discontinuation rate : 6-10% due to adverse events The glucagon receptor component introduces theoretical concerns for hyperglycemia (counterbalanced by GLP-1/GIP in practice), cardiovascular effects (chronotropic glucagon action), and hepatic effects, none of which produced safety signals in Phase 2 but require larger-scale monitoring
Common side effects (affecting more than 10% of users) Nausea is the most frequently reported side effect, particularly during the first few weeks and after dose increases
This may occur in part because tirzepatide's effect on gastric emptying could potentially influence reflux patterns in susceptible individuals
Yes, but continuous refrigeration at 28C is mandatory throughout travel use an insulated medication cooler with ice packs or a portable insulin cooler that maintains refrigeration temperature for 2448 hours without electricity
This study clarified the potential mechanism of PFOS-mediated RTC apoptosis and provided a new strategy for using l-Carnitine to prevent and treat PFOS-induced RTC apoptosis
